BAYER AG SPON ADR EACH REP 0.25 (BAYRY) Financials
BAYRY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 129.4 billion | 90.8 billion |
| 2023-12-31 | 136.4 billion | 99.8 billion |
| 2023-09-30 | 124.1 billion | 88.6 billion |
| 2023-06-30 | 132.3 billion | 91.9 billion |
BAYRY Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | -2.8 billion | ? |
| 2023-12-31 | 4.7 billion | 169.1 million |
| 2023-09-30 | 2.0 billion | ? |
| 2023-06-30 | -132.7 million | ? |
BAYRY Net Income
| Date | Net Income |
|---|---|
| 2024-03-31 | 2.2 billion |
| 2023-12-31 | 1.5 billion |
| 2023-09-30 | -4.8 billion |
| 2023-06-30 | -2.1 billion |
BAYRY Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 5.1 billion | - | - |
| 2023-12-31 | 11.7 billion | - | 1.4 billion |
| 2023-09-30 | 9.9 billion | - | - |
| 2023-06-30 | 8.3 billion | - | - |
BAYRY Shares Outstanding
BAYRY Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | 481.3 million | 1.5 billion | - | - |
| 2023-12-31 | 1.1 billion | 1.2 billion | 834.6 million | 3.1 billion |
| 2023-09-30 | 723.1 million | 1.6 billion | 583.3 million | 3.2 billion |
| 2023-06-30 | 658.9 million | 1.3 billion | 531.7 million | 3.5 billion |
BAYRY Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 14.9 billion | 5.9 billion |
| 2023-12-31 | 13.1 billion | 5.0 billion |
| 2023-09-30 | 10.9 billion | 5.1 billion |
| 2023-06-30 | 12.0 billion | 5.1 billion |
BAYRY
Price: $7.72
Dividend Yield: 0.37%
Forward Dividend Yield: 0.38%
Payout Ratio: -3.69%
Dividend Per Share: 0.03 USD
Earnings Per Share: -0.80 USD
P/E Ratio: -7.54
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 2.8 million
Market Capitalization: 31.3 billion
Average Dividend Frequency: 1
Years Paying Dividends: 28
DGR3: -7.82%
DGR5: -6.50%